cvot tirzepatide SURPASS-CVOT Shows Mounjaro Surpasses Trulicity in CV Outcomes In patients with type 2
Description
This makes proper medication handling and sterile injection technique even more important than for the general population
It also highlights the importance of looking past the scale and considering body composition, mental wellbeing, and patient-reported outcomes when evaluating treatment effects
Oral semaglutide begins at $249 monthly and provides an alternative for needle-averse patients willing to accept a slightly longer onset window
an increase in score indicating worsening as the disease progresses 6,7
